期刊文献+

肥厚型心肌病的局部心肌功能变化和分子遗传学基础 被引量:2

Regional myocardial function and genetic bases in patients with hypertrophic cardiomyopathy
原文传递
导出
摘要 肥厚型心肌病是一类常染色体显性遗传性疾病,多数为编码心肌肌原纤维的基因突变所致。常见的突变基因为肌球蛋白重链基因、肌球蛋白结合蛋白C基因、肌钙蛋白基因、廿原肌球蛋白基因以及一些非肌小节基因。不同的基因突变导致的肥厚型心肌病其局部心肌收缩及舒张运动也出现不同程度的改变:收缩运动减弱;Ca^2+敏感性增加,舒张功能减退。该文从遗传学角度阐述了以上常见基因突变造成的不同心肌功能变化,并从基因水平解释了不同基因突变造成不同心肌运动功能改变的原因。 Hypertrophic cardiomypathy is a genetically heterogeneous cardiac disease transmitted as an autosomal dominant trait,mostly caused by mutant of myofribriUa gene such as βMHC, MYBPC3, cTnT, cTnI,cTnC, a-Tm and some other gene which coding non-myofribrilla. Different mutant caused different regional myocardium systolic or diastole function, which involve in dysfunction of systolic and diastohc deformation, increase of the sensitive of Ca^2+. This review summarizes the most common gene mutations in hypertrophic cardiomypathy and explains the changes of myocardial functions.
出处 《国际儿科学杂志》 2010年第3期297-300,共4页 International Journal of Pediatrics
关键词 心肌病 肥厚型 应变 基因突变 Cardiomyopathy, hypertrophic Strain Gene mutation
  • 相关文献

参考文献4

二级参考文献94

  • 1[1]Maron BJ,Gardin JM,Flack JM,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995; 92:785-789
  • 2[2]Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001; 104(4):557-67
  • 3[3]Bonne , Carrier L, Richard P. Familial Hypertrophic Cardiomyopathy: From Mutations to Functional Defects. Cir Res. 1998; 83:580-593.
  • 4[4]Marian A J, Roberts R. The Molecular Genetic Basis for Hypertrophic Cardiomyopathy. J Mol Cell Cardio 2001; 33:655-670
  • 5[5]Matsuoka R, Yoshida MC, Kanda N, et al. Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2-q13. Am J Med Genet. 1989; 32:279-284
  • 6[6]Liew CC, Sole M J, Yamauchi TK, et al.Completesequence and organization of the human cardiac b-myosin heavy chain gene. Nucleic Acids Res. 1990;18:3647-3651
  • 7[7]Fougerousse F, Dufour C, Roudaut C, et al.Dinucleotide repeat polymorphism at the human gene for cardiac beta-myosin heavy chain. Hum Mol Genet. 1992;1:64-69
  • 8[8]Sata M, Stafford WF, Mabuchi K, et al. The motor domain and the regulatory domain of myosin solely dictate enzymatic activity and phosphorylation-dependent regulation respectively. Proc Natl Acad Sci USA.1997; 94:91-96
  • 9[9]Seidman CE, Seidman JG. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol 1998; 93 (Suppl) 3:13-16
  • 10[10]Rayment I, Holden HM, Sellers JR, et al. Structural interpretation of the mutations in the b-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 1995;92:3864-3868

共引文献5

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部